Location History:
- Stockport, GB (2001)
- Furness Vale Perstsure, GB (2003)
- Cheshire, GB (2007)
- Derbyshire, GB (2008 - 2010)
- Furness Vale, GB (2010)
- Manchester, GB (2011)
Company Filing History:
Years Active: 2001-2011
Title: Innovations by Mark William James Ferguson: Advancements in TGF-β3 Technology
Introduction
Mark William James Ferguson, an accomplished inventor based in Manchester, GB, has made significant contributions to the field of biotechnology. With an impressive portfolio comprising nine patents, his work focuses on innovative methods utilizing TGF-β3, a crucial protein in cellular processes. His patents not only illustrate his expertise but also showcase the potential for medical advancements through his inventions.
Latest Patents
Ferguson's latest patents center around innovative formulations and uses of TGF-β3 mutants. His inventions provide TGF-β3s with alterations designed to stabilize alpha-helical structures, enhancing their functionality. These mutants include specific substitutions, such as replacing the Glycine residue at position 63 with Proline and modifying the Glutamic acid residue at position 12 and the Arginine residue at position 52 of the full-length wild type TGF-β3. Further, he has developed medicaments and methods employing these proteins for treating wounds, promoting epithelial regeneration, and preventing fibrotic disorders, highlighting their potential therapeutic applications.
Career Highlights
Ferguson is affiliated with Renovo Limited, where his work is at the forefront of regenerative medicine. The company's dedication to advancing therapeutic agents is a perfect match for Ferguson's innovative vision. His contributions have the potential to provide groundbreaking solutions in treatments for wounds and fibrotic conditions, marking a significant milestone in his career as an inventor.
Collaborations
Throughout his career, Ferguson has collaborated with notable colleagues, including Phillip Mellors and Hugh Gerard Laverty. These partnerships have fostered a creative environment for innovation, enabling the development of his revolutionary patents and shared advancements in TGF-β3 technology.
Conclusion
Mark William James Ferguson stands out as an influential figure in biotechnology innovation. His extensive patent portfolio and ongoing research reflect a deep commitment to advancing medical technology. With his inventiveness and collaborative spirit, he continues to pave the way for future breakthroughs, particularly in wound healing and tissue regeneration. Ferguson's innovations not only enhance scientific knowledge but also hold promise for substantial improvements in patient care and therapeutic options.